• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back

Diuretics

MOA: decr. fluid and PVR


Effect:

ACEi

MOA: inhibit conversion of ATI to ATII via ACE


Major Effect: decrease PVR and BP


Decrease: vasoconstriction, aldosterone, fibrosis, ADH, degradation of bradykinin (VD), efferent arterial resistance, microalbuminuria

ARBs

MOA: Competitive antagonist of ATII at the AT1 receptor


Major Effect: decrease TPR and BP


Decrease: vasoconstriction, aldosterone, ADH, catecholamine release


Increase: AT2 activity = vasodilation

Direct Renin Inhibitors

Aliskiren


See ACEi; similar decr. in BP

Beta Blocker

MOA:


Effect: lower BP


Decrease: CO, renin, sympathetic outflow

Beta Receptor Stimulation

BV: dilation


Heart: incr. tachycardia and induce contractility

Alpha Receptor Stimulation

BV: constriction


Heart: incr. contractility

Alpha Blockers

MOA: at a post-synaptic alpha 1 receptor to prevent catecholamine induced vasoconstriction


Effect: arterial and venous dilation, decr. TPR and decr. arterial pressure

CCB

MOA: block channel from allowing Ca to enter cardiac and SM


Effect:Arterial vasodilators, decr. rate and force of contraction, decr. BP

Minoxidil

MOA: opens ATP modulated K channel causing hyperpolarization, a decr. in Ca entry and relaxation of SM


Effect: decr. TPR and BP

Hydralazine

Decr. TPR and BP

Sodium Nitroprusside

MOA: breaks down in NO


Major: decr. TPR and BP


Effect: venous pooling, decr. arterial resistance



Other Nitrates

MOA: enzymatically converted to NO


Effect: vasodilation, decr. preload and afterload (decr. heart O2 requirements)

Clonidine

MOA: stimulate a2 receptors in the brain, decr. sympathetic outflow and BP


Decreases: TPR, HR, CO, BP

Methyldopa

MOA: depletes source of norepi (VC) but mainly stimulate a2 receptors in the brain, decr. sympathetic outflow


Decreases: TPR, CO, BP